- Filed
- Nov 13, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · Nov 4, 2024 | 15.92M sh |
| Shares Diluted | Q3 2024 · Sep 30, 2024 | 15.02M sh |
| Shares Diluted | Q3 2024 · Sep 30, 2024 | 14.41M sh |
| Shares Diluted | Q3 2024 · Sep 30, 2023 | 13.88M sh |
| Shares Diluted | Q3 2024 · Sep 30, 2023 | 13.3M sh |
| Cash And Equivalents | Q3 2024 · Sep 30, 2024 | $3.59M |
| Cash And Equivalents | Q3 2024 · Dec 31, 2023 | $432K |
| Current Liabilities | Q3 2024 · Sep 30, 2024 | $1.25M |
| Current Liabilities | Q3 2024 · Dec 31, 2023 | $968K |
| Total Liabilities | Q3 2024 · Sep 30, 2024 | $1.47M |
| Total Liabilities | Q3 2024 · Dec 31, 2023 | $968K |
| Current Assets | Q3 2024 · Sep 30, 2024 | $3.97M |
| Current Assets | Q3 2024 · Dec 31, 2023 | $783K |
| Total Assets | Q3 2024 · Sep 30, 2024 | $5.31M |
| Total Assets | Q3 2024 · Dec 31, 2023 | $2.61M |
| Eps Diluted | Q3 2024 · Sep 30, 2024 | −$0.12 |
| Eps Diluted | Q3 2024 · Sep 30, 2024 | −$0.44 |
| Eps Diluted | Q3 2024 · Sep 30, 2023 | −$0.12 |
| Eps Diluted | Q3 2024 · Sep 30, 2023 | −$0.54 |
| Capex | Q3 2024 · Sep 30, 2023 | $11K |
| Operating Cash Flow | Q3 2024 · Sep 30, 2023 | −$5.72M |
| Stockholders Equity | Q3 2024 · Sep 30, 2023 | $2.72M |
| Stockholders Equity | Q3 2024 · Jun 30, 2023 | $3.8M |
| Stockholders Equity | Q3 2024 · Dec 31, 2022 | −$3.19M |
| Eps Basic | Q3 2024 · Sep 30, 2023 | −$0.12 |
| Eps Basic | Q3 2024 · Sep 30, 2023 | −$0.54 |
| Rd Expense | Q3 2024 · Sep 30, 2023 | $339K |
| Rd Expense | Q3 2024 · Sep 30, 2023 | $2.41M |
| Net Income | Q3 2024 · Sep 30, 2023 | −$1.62M |
| Net Income | Q3 2024 · Sep 30, 2023 | −$7.12M |
| Operating Income | Q3 2024 · Sep 30, 2023 | −$1.62M |
| Operating Income | Q3 2024 · Sep 30, 2023 | −$7.16M |
| Revenue | Q3 2024 · Sep 30, 2023 | $40K |
| Revenue | Q3 2024 · Sep 30, 2023 | $40K |